Overexpression of the MT1 melatonin receptor in MCF-7 human breast cancer cells inhibits mammary tumor formation in nude mice

Cancer Letters

Volumn 189, Issue 1, 2003, Pages 49-57

  Collins, A ^a,b   Yuan, L ^a,b   Kiefer, T L ^a,b   Cheng, Q ^a,b   Lai, L ^a,b   Hill, S M ^a,b  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Athymic nude mice; Breast cancer; Melatonin; MT1 receptor

Indexed keywords

MELATONIN; MELATONIN RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST TUMOR; CANCER CELL; CANCER INCIDENCE; CANCER INHIBITION; CANCER TRANSPLANTATION; CARCINOGENESIS; CELL STRAIN MCF 7; CELL TRANSFORMATION; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; GENE OVEREXPRESSION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL;

ANIMALS; BREAST NEOPLASMS; FEMALE; HUMANS; MELATONIN; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, MELATONIN; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS; MUS MUSCULUS;

EID: 0037427569     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00502-5     Document Type: Article

References (24)

1. Blask D.E., Hill S.M., Orstead K.M., Massa J.S. Inhibitory effects of the pineal hormone melatonin and underfeeding during the promotional phase of 7,12-dimethylbenzanthracine (DMBA)-induced mammary tumorigenesis. J. Neural Transm. 67:1986;125-138.
2. Blask D.E., Hill S.M. Effects of melatonin on cancer: studies on MCF-7 human breast cancer cells in culture. J. Neural Transm. 29:1986;406-412.
3. Blask D.E., Sauer L.A., Dauchy R.T., Holowachuk E.W., Ruhoff M.S. New insights into melatonin regulation of cancer growth. Adv. Exp. Med. Biol. 460:1999;337-343.
4. Cos S., Sanchez-Barcelo E. Melatonin inhibition of MCF-7 human breast-cancer cells growth: influence of cell proliferation rate. Cancer Lett. 93:1995;207-212.
5. Hill S.M., Blask D.E. Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res. 48:1988;6121-6126.
6. Subramanian A., Kothari L. Melatonin, a suppressor of spontaneous murine mammary tumors. J. Pineal Res. 10:1991;136-140.
7. Tamarkin L., Cohen M., Roselle D., Reichert C., Lippman M., Chabner B. Melatonin inhibition and pinealectomy enhancement of 7,12 dimethylbenz(a)anthracene-induced mammary tumors in the rat. Cancer Res. 41:1981;4432-4436.
8. Sanchez-Barcelo E.J., Mediavilla M.D., Tucker H.A. Influence of melatonin on mammary gland growth: in vivo and in vitro studies. Soc. Exp. Biol. Med. 194:1990;103-107.
9. Blask D.E., Pelleteir D.B., Hill S.M., Lemus-Wilson A., Grosso D.S., Wilson S.T., Wise M.E. Pineal melatonin inhibition of tumor promotion in the NMU mammary model of carcinogenesis: potential involvement of mechanism in vivo. J. Cancer Res. Clin. Oncol. 117:1991;526-532.
10. Reiter R.J. The pineal and its hormones in the control of reproduction in mammals. Endocr. Rev. 1:1980;109-131.
11. Maestroni G.J. The immunoneuroendocrine role of melatonin. J. Pineal Res. 14:1993;1-10.
12. Maestroni G.J., Conti A., Lissoni P. Colony-stimulating activity and hematopoietic rescue from cancer chemotherapy compounds are induced by melatonin via endogenous interleukin 4. Cancer Res. 54:1994;4740-4743.
13. Maestroni G.J., Covacci V., Conti A. A hematopoietic rescue via T-cell-dependent, endogenous granulocyte-macrophage colony-stimulating factor induced by the pineal neurohormone melatonin in tumor-bearing mice. Cancer Res. 54:1994;2429-2432.
14. Maestroni G.J., Conti A. Melatonin in human breast cancer tissue: association with nuclear grade and estrogen receptor status. Lab. Invest. 75:1996;557-561.
15. Hill S.M., Spriggs L.L., Simon M.A., Muraoka H., Blask D.E. The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system. Cancer Lett. 64:1992;249-256.
16. Molis T.M., Walters M.R., Hill S.M. Melatonin modulation of estrogen receptor mRNA in MCF-7 breast cancer cells. Int. J. Oncol. 3:1993;687-694.
17. Molis T.M., Spriggs L.L., Hill S.M. Modulation of estrogen receptor mRNA expression by melatonin in MCF-7 human breast cancer cells. Mol. Endocrinol. 8:1994;1681-1690.
18. Molis T.M., Spriggs L.L., Jupiter Y., Hill S.M. Melatonin modulation of estrogen-regulated proteins, growth factors, and proto-oncogenes in human breast cancer. J. Pineal Res. 18:1995;93-103.
19. Ram P.T., Kiefer T., Silverman M., Song Y., Brown G.M., Hill S.M. Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors. Mol. Cell. Endocrinol. 141:1998;53-64.
20. Yuan L., Collins A.R., Dai J., Dubocovich M.L., Hill S.M. Overexpression of the mt1 melatonin receptor enhances melatonin's growth-suppression of human breast cancer cells. Mol. Cell. Endocrinol. 192:2002;147-156.
21. Reppert S.M., Weaver D.R., Ebisawa T. Cloning and characterization of a melatonin receptor that mediates reproductive and circadian responses. Neuron. 13:1994;1177-1185.
22. Ram P.T., Yuan L., Dai J., Kiefer T., Klotz D.M., Spriggs L.L., Hill S.M. Differential responsiveness of MCF-7 human breast cancer cell line stocks to the pineal hormone melatonin. J. Pineal Res. 28:2000;210-218.
23. Roka F., Brydon L., Waldhoer M., Strosberg A.D., Freissmuth M., Jockers R., Nanoff C. Tight association of the human Mel(1a)-melatonin receptor and G(i): precoupling and constitutive activity. Mol. Pharmacol. 56:1999;1014-1024.
24. Guerrero H.Y., Gauer F., Schuster C., Pevet P., Masson-Pevet M. Melatonin regulates the mRNA expression of the mt1 melatonin receptor in the rat pars tuberalis. Neuroendocrinology. 71:2000;163-169.